Quinn, Kevin2008-02-052008-02-052008-02-05https://hdl.handle.net/11299/5649The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.Liver damage from isoniazid therapy for latent tuberculosis occurs in 5-10 people per 1000 patients. The risk is greatest in those over 35 years of age.LatentTuberculosisisoniazidOther